N/A Completed N=66 Randomized Double-blind Treatment

My Mobile Advice Program: A Randomized Pilot Feasibility Study

Smoking Cessation · Medication Adherence

Source: ClinicalTrials.gov NCT02136498 ↗

Enrolled (actual)

Serious AEs

1.5%

Results posted

Oct 2016

Primary outcomePrimary: Point Prevalence Abstinence — 24; 36 Percentage of people not smoking

Summary

The purpose of this pilot study is to evaluate the acceptability and feasibility of the proposed smoking cessation intervention (called MyMAP or My Mobile Advice Program).

Outcome Measures

Outcome	Result	p-value
PRIMARY Point Prevalence Abstinence	24; 36	—
SECONDARY Number of Days of Varenicline Use	39; 46	—

Eligibility Criteria

Inclusion Criteria

An invited member of Group Health, a health care system in the Pacific Northwest
Plan to remain enrolled in Group Health for the next 6 months
aged 18 - 65
Eligible for smoking cessation treatment through Group Health insurance coverage
smoke >= 10 cigs a day
speak and read in English
willing to use varenicline and no contraindications for this medication
ready to quit smoking
have a smart phone with internet access
willing to receive study texts and emails
receive care at a Group Health clinic and have electronic medical records in this system
fill prescriptions through the Group Health pharmacy
agree to use birth control while taking study medication, if there is a risk of pregnancy

Exclusion Criteria

lifetime history of dementia
psychosis or bipolar disorder based on self-report or medical record review
hearing, comprehension or visual limitations that preclude full study participation
current use of other forms of tobacco
any medical contraindication for varenicline use
documented history of suicidal ideation/intent

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02136498). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.